×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [26]
内容类型
期刊论文 [26]
发表日期
2019 [10]
2018 [6]
2017 [6]
2016 [3]
2014 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共26条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer
期刊论文
2019, 卷号: 70, 期号: 1, 页码: 198-214
作者:
Wu, Qinchuan
;
Zhou, Wuhua
;
Yin, Shengyong
;
Zhou, Yuan
;
Chen, Tianchi
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/01/03
PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma
期刊论文
2019, 卷号: 84, 页码: 291-298
作者:
Guo, Wei
;
Zhang, Fan
;
Shao, Fei
;
Wang, Pan
;
Li, Zitong
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/01/03
Esophageal squamous cell carcinoma
Programmed cell death ligand 1
Prognosis
Immunohistochemistry
Biomarker
Clinical significance of >= 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients
期刊论文
2019, 卷号: 10, 期号: 2, 页码: 175-182
作者:
Li, Wenbin
;
Song, Peng
;
Guo, Lei
;
Liu, Xiuyun
;
Guo, Changyuan
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
Driver mutation
non-small cell lung cancer
programmed death ligand 1
smoking
Clinicopathologic Correlation With Expression of PD-L1 on Both Tumor Cells and Tumor-infiltrating Immune Cells in Patients With Non-Small Cell Lung Cancer
期刊论文
2019, 卷号: 42, 期号: 1, 页码: 23-28
作者:
Song, Peng
;
Guo, Lei
;
Li, Wenbin
;
Zhang, Fan
;
Ying, Jianming
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2020/01/03
programmed death-ligand 1 (PD-L1)
non-small cell lung cancer (NSCLC)
tumor-infiltrating immune cells
driver mutation
smoking
PD-1/PD-L1 expressions in medullary thyroid carcinoma: Clinicopathologic and prognostic analysis of Chinese population
期刊论文
2019, 卷号: 45, 期号: 3, 页码: 353-358
作者:
Bi, Yalan
;
Ren, Xinyu
;
Bai, Xiaohui
;
Meng, Yunxiao
;
Luo, Yufeng
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Medullary thyroid carcinoma (MTC)
Programmed cell death protein 1 (PD-1)
Programmed death-ligand 1 (PD-L1)
Distant metastasis at surgery
Progression free survival
Overall survival
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China
期刊论文
2019, 卷号: 125, 期号: 5, 页码: 742-749
作者:
Huang, Jing
;
Mo, Hongnan
;
Zhang, Weilong
;
Chen, Xuelian
;
Qu, Dong
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/01/03
B7-H1 antigen
DNA mismatch repair
l-lactate dehydrogenase
programmed cell death 1 receptor
stomach neoplasms
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody
期刊论文
2019, 卷号: 10, 期号: 6, 页码: 1395-1401
作者:
Wang, Xi
;
Zhang, Bo
;
Chen, Xuelian
;
Mo, Hongnan
;
Wu, Dawei
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Esophageal squamous cell carcinoma
immune checkpoint inhibitor
lactate dehydrogenase
markers
programmed cell death-1
Hypoxia-inducible factor-1 alpha and nuclear factor-kappa B play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells
期刊论文
2019, 卷号: 110, 期号: 5, 页码: 1665-1675
作者:
Guo, Rong
;
Li, Yong
;
Wang, Zhijie
;
Bai, Hua
;
Duan, Jianchun
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
epidermal growth factor receptor
Hypoxia-inducible factor-1 alpha
NF-kappa B
non-small-cell lung cancer
programmed cell death ligand 1
Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells
期刊论文
2019, 卷号: 8, 期号: 5, 页码: 2104-2113
作者:
Zhang, Wei
;
Shen, Haorui
;
Zhang, Yan
;
Wang, Wei
;
Hu, Shaoxuan
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
adaptive immune
chidamide
innate immune
peripheral T-cell lymphoma
programmed cell death-1
Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis
期刊论文
2019, 卷号: 24, 期号: 1, 页码: 392-398
作者:
Shen, Haorui
;
Ji, Yali
;
Zhou, Daobin
;
Zhang, Yan
;
Wang, Wei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Peripheral T-cell lymphoma
programmed cell death ligand 1
prognosis
©版权所有 ©2017 CSpace - Powered by
CSpace